| All Releases |
 |
May 10, 2010
Warner Chilcott to Present at the Bank of America Merrill Lynch Healthcare Conference |
 |
 |
| |
ARDEE, Ireland, May 10, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will present at the Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 11, 2010 at 8:00 a.m. EDT. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice President and Chief Financial Office... |
|
|
May 7, 2010
Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2010 |
|
|
| |
ARDEE, Ireland, May 7, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter ended March 31, 2010. Revenue in the quarter was $761.3 million, an increase of $515.3 million, or 209.5%, over the prior year quarter. The primary drivers of the increase in revenue were the products ac... |
|
|
April 29, 2010
Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2010 Financial Results |
|
|
| |
ARDEE, Ireland, April 29, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its first quarter 2010 financial results prior to the market opening on Friday, May 7, 2010.
In addition to issuing a press release, the Company will host a conference call for all interested parties on Frida... |
|
|
April 5, 2010
Warner Chilcott Announces Amendment to Actonel Collaboration Agreement with sanofi-aventis |
|
|
| |
ARDEE, Ireland, April 5, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) and sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today an amendment to the Actonel(R) global collaboration agreement with respect to the parties' arrangement in the United States and Puerto Rico. Under the terms of the amendment, Warn... |
|
|
March 1, 2010
Warner Chilcott to Present at the RBC Capital Markets Healthcare Conference |
|
|
| |
ARDEE, Ireland, March 1, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will present at the RBC Capital Markets Healthcare Conference on Wednesday, March 3, 2010 at 11:00 a.m. EST. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice President and Chief Financial Officer.
W... |
|
|
March 1, 2010
Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2009 |
|
|
| |
ARDEE, Ireland, March 1, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter and year ended December 31, 2009. Revenue in the quarter was $686.2 million, an increase of $443.7 million, or 183.0%, over the prior year quarter revenue of $242.5 million. The primary drivers of the ... |
|
|
February 25, 2010
Warner Chilcott Announces Earnings Release Date and Conference Call For Fourth Quarter and Full Year 2009 Financial Results |
|
|
| |
ARDEE, Ireland, Feb 25, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its fourth quarter and full year 2009 financial results prior to the market opening on Monday, March 1, 2010.
In addition to issuing a press release, the Company will host a conference call for all interested ... |
|
|
January 29, 2010
Warner Chilcott Announces 2010 Financial Guidance |
|
|
| |
ARDEE, Ireland, Jan 29, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today a view of anticipated full year 2010 results.
Adjusted total revenues for 2010, after excluding the impact of the Company's distribution agreement with LEO Pharma A/S ("LEO"), are expected to be in the range of $2.9 to $2.95 bil... |
|
|
January 27, 2010
FDA Issues Complete Response Letter for Low Dose Oral Contraceptive |
|
|
| |
ARDEE, Ireland, Jan 27, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it has received a complete response letter from the U.S. Food and Drug Administration (FDA) to its New Drug Application submitted in March 2009 for its "low dose" oral contraceptive (also referred to as WC 3016).
The letter... |
|
|
January 25, 2010
Warner Chilcott Announces 2010 Financial Guidance Conference Call |
|
|
| |
ARDEE, Ireland, Jan 25, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its 2010 Financial Guidance before market open on Friday, January 29, 2010. In addition to issuing a press release, Roger Boissonneault, President and Chief Executive Officer and Paul Herendeen, Executive Vice... |
|
|
January 5, 2010
Warner Chilcott to Present at the 28th Annual J.P. Morgan Healthcare Conference |
|
|
| |
ARDEE, Ireland, Jan 05, 2010 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will present at the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2010 at 11:30 a.m. PST. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice President and Chief Financi... |
|
|
December 30, 2009
Warner Chilcott Announces Early Tender Results and Receipt of Consents from a Majority of Holders of its 8-3/4% Senior Subordinated Notes due 2015 |
|
|
| |
ARDEE, Ireland, Dec 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 9... |
|
|
December 15, 2009
Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 |
|
|
| |
ARDEE, Ireland, Dec 15, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that its subsidiary Warner Chilcott Corporation (the "Company") has commenced a cash tender offer, on the terms and subject to the conditions set forth in the Company's Offer to Purchase and Consent Solicitation Statemen... |
|
|
December 15, 2009
Warner Chilcott Affirms Global Marketing and Collaboration Agreement With Sanofi-Aventis |
|
|
| |
ARDEE, Ireland, Dec 15, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that Sanofi-Aventis U.S. LLC ("Sanofi") has elected not to exercise its right to put its interest in the global marketing and collaboration agreement (the "Marketing Agreement"). As previously disclosed, Warner Chilcott... |
|
|
December 11, 2009
Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes |
|
|
| |
ARDEE, Ireland, Dec 11, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- As Warner Chilcott plc (Nasdaq: WCRX) has previously disclosed, its acquisition of the global branded prescription pharmaceuticals business of The Procter & Gamble Company ("P&G") on October 30, 2009 (the "PGP Acquisition"), constituted a change of control under a global... |
|
|
November 19, 2009
Warner Chilcott Prices Secondary Equity Offering |
|
|
| |
ARDEE, Ireland, Nov 19, 2009 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced the pricing of its previously announced secondary offering of 20,000,000 of its ordinary shares at a price to the public of $22.25 per share. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merch... |
|
|
November 13, 2009
Warner Chilcott Announces Secondary Equity Offering |
|
|
| |
ARDEE, Ireland, Nov 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced a 20,000,000 share secondary offering of its ordinary shares by certain selling shareholders. The selling shareholders include funds affiliated with Bain Capital Partners, DLJ Merchant Banking, J.P. Morgan Partners (adv... |
|
|
November 9, 2009
Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2009 |
|
|
| |
ARDEE, Ireland, Nov 09, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced its results for the quarter ended September 30, 2009. Revenue in the quarter ended September 30, 2009 increased 9.0% to $252.8 million over the prior year quarter. The primary drivers of the increase in revenue in the qu... |
|
|
November 2, 2009
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2009 Financial Results |
|
|
| |
ARDEE, Ireland, Nov 02, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its third quarter 2009 financial results prior to the market opening on Monday, November 9, 2009.
In addition to issuing a press release, the Company will host a conference call for all interested par... |
|
|
October 30, 2009
Warner Chilcott Completes Acquisition of P&G's Global Branded Prescription Pharmaceuticals Business |
|
|
| |
ARDEE, Ireland, Oct 30, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today it has completed the acquisition of The Procter & Gamble Company's global branded prescription pharmaceutical business. The acquisition complements Warner Chilcott's existing presence in women's health care and adds new... |
|
|
|
Investor Relations
